Publications by authors named "Kim Bure"

Claim this Profile
B
Bioprocess decision support tool for scalable manufacture of extracellular vesicles.
Kelvin S Ng, James A Smith, Matthew P McAteer, Benjamin E Mead, Jamie Ware, Kim Bure

Biotechnol Bioeng· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop.
Oliver Ball, Sarah Robinson, Kim Bure, David A Brindley, David Mccall

Cytotherapy· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies.
Benjamin M Davies, James Smith, Sarah Rikabi, Karolina Wartolowska, Mark Morrey, Kim Bure

J Tissue Eng· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol.
David Pettitt, Zeeshaan Arshad, Benjamin Davies, James Smith, Anna French, Kim Bure

Syst Rev· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Access Could Transform Drug Discovery: A Case Study of JQ1.
Zeeshaan Arshad, James Smith, Mackenna Roberts, Wen Hwa Lee, Ben Davies, Kim Bure

Expert Opin Drug Discov· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.
Dee Luo, James A Smith, Nick A Meadows, Anna Schuh, Katie E Manescu, Kim Bure

Front Genet· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.
Dee Luo, James A Smith, Nick A Meadows, A Schuh, Katie E Manescu, Kim Bure

Front Genet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.
Anna French, Christopher Bravery, James Smith, Amit Chandra, Peter Archibald, Kim Bure

Stem Cells Transl Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
Marli Silva, Laurence Daheron, Hannah Hurley, Kim Bure, Richard Barker

Cell Stem Cell· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
Benjamin M Davies, Sarah Rikabi, Anna French, Rafael Pinedo-Villanueva, Mark E Morrey, Kim Bure

J Tissue Eng· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global strategic partnerships in regenerative medicine.
Anna French, Jane Y Suh, Carol Y Suh, Lee Rubin, Richard Barker, Kim Bure

Trends Biotechnol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global intellectual property landscape of induced pluripotent stem cell technologies.
MacKenna Roberts, Ivan B Wall, Ian Bingham, Dominic Icely, Brock Reeve, Kim Bure

Nat Biotechnol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.
Anna French, Kim Bure, David A Brindley

Rejuvenation Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.
David A Brindley, Anna French, Jane Suh, MacKenna Roberts, Benjamin Davies, Kim Bure

Stem Cells Dev· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis